摘要
长期以来,我国的一类新药研发与欧美发达国家相比存在较大差距,目前尚无一项拥有自主知识产权的新药产品能在国际医药市场上占据一席之地。为尽早打破跨国药企在医药高端市场上的垄断地位,我国企业应加速国内外医药技术合作与转移,实现医药行业的跨越式发展。
出处
《中国经贸》
2011年第11期68-69,共2页
China Global Business
同被引文献20
-
1沈枫,李野,董丽丽.跨国制药企业研发国际化及对我国的启示[J].中国新药杂志,2004,13(12):1078-1080. 被引量:4
-
2Rafols I, Hopkins M M, Hoekman J, et al. Big Pharma,little science? :A bibliometric perspective on Big Pharma's R&D decline[J]. Technol Forecast Soc Change,2012, doi: 10. 1016/j. techfore. 2012.06.007. http ://sciencedirect. corn/ science/article/pii/S0040162512001540 ? np=y.
-
3Adams C P, Brantner V V. Spending on new drug develop- mentl [ J]. Health Econ ,2010,19 (2) : 130-141.
-
4Munos B. Lessons from 60 years of pharmaceutical innova- tion[ J]. Nat Rev Drug D/scov,2009,8(12) :959-968.
-
5Light D W, Lexchin J R. Pharmaceutical research and development:what do we get for all that money? [ J ]. Br Med J,2012(345 ) :e4348.
-
6Schuhmacher A, Germann P G, Trill H, et al. Models for open innovation in the pharmaceutical industry [ J/OL ]. Drug Discov Today,2013, doi: 10. 1016/j. drudis. 2013. 07. 013. http://www, sciencedirect, corn/science/article/ pii/S135964461300247X.
-
7Gassmann O, Reepmeyer G, Von Zedtwitz M. Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry [ M ]. Berlin : Springer, 2008.
-
8Wellenreuther R, Keppler D, Mumberg D,et al. Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare [ J ]. Drug Discov Today,2012,17 (21) : 1242-1248.
-
9Correa C M. Towards a new model for pharmaceutical re- search[ J ]. Bull World Health Organ,2012(90 ) :795-795A.
-
10付翌秋.三方合作势不可当[N].医药经济报,2012,6:A9.
-
1哈药两则[J].中国制药信息,2002,18(10):7-8.
-
2王广良.仿制药如何低成本快速完成FDA要求的临床试验[J].生物医药世界,2001(C00):18-22.
-
3中药进军国际市场的启示[J].医药简讯(广州),2002(11):24-24.
-
4汉殷药业顺利通过GMP认证[J].国内外香化信息,2002(12):12-12.
-
5徐国英.中国加入世贸后的中药行业分析[J].化工文摘,2002(4):52-52. 被引量:1
-
6肖扬.入世后,中药产业的出路[J].首都医药,2002,9(11):9-10.
-
7迎接仿制药的“春天”[J].中国药业,2004,13(4):19-19.
-
8薛茁.中药行业入世前瞻的思考[J].中国中医药信息杂志,2002,9(11):1-2. 被引量:1
-
9茅宁莹,顾海.印度企业新药的成功研发及启示[J].江苏企业管理,2005(7):43-44. 被引量:1
-
10于明德.2006医药企业,路在何方?[J].中国医药指南,2006,4(1):11-12.